PI11305 2-Mercapto-5-Methoxybenzimidazole (CAS No.: 37052-78-1)

2-Mercapto-5-Methoxybenzimidazole (CAS No.: 37052-78-1) Description

2-Mercapto-5-Methoxybenzimidazole (C8H8N2OS) is a well-characterised intermediate used in pharmaceutical manufacturing. Its structure provides reactive sites essential for producing targeted chemical modifications. The powder form supports precise dosing and reproducibility in synthetic processes. Analytical verification via HPLC and NMR confirms the compound's consistent chemical properties, making it suitable for controlled laboratory and production environments.

2-Mercapto-5-Methoxybenzimidazole (CAS No.: 37052-78-1) Applications

1.         Pharmaceutical Manufacturing
- Used as a key synthetic intermediate in the preparation of active pharmaceutical ingredients to achieve controlled chemical modification by leveraging its reactive functional groups.

2.         Chemical Synthesis
- Applied as a reagent in heterocyclic synthesis for the development of complex molecules by supporting specific reaction mechanisms and ensuring batch consistency.

3.         Research and Development
- Frequently used in laboratory studies to explore structure-activity relationships by providing a reproducible and well-defined chemical entity.

2-Mercapto-5-Methoxybenzimidazole (CAS No.: 37052-78-1) Packing

The compound is packaged in airtight, moisture-resistant containers with an inner lining to prevent contamination and environmental exposure. Each package is securely sealed and labelled with batch-specific details to support traceability. Storage conditions specify a cool, dry environment to preserve chemical integrity. Custom packaging options are available, including secondary containment and specialised labelling to meet laboratory or manufacturing requirements.

Additional Information

Understanding the role of chemical intermediates like 2-Mercapto-5-Methoxybenzimidazole is essential in pharmaceutical process development. The synthesis of complex active ingredients often depends on intermediates with defined reactivity and stability profiles. Detailed analytical methods and controlled storage conditions are critical to ensure that these compounds contribute effectively to the overall manufacturing process.

Materials used in synthesis require a high degree of reproducibility and precise characterisation. Contemporary analytical techniques and standardised procedures facilitate the integration of such intermediates into regulated production environments, supporting both innovation in drug development and compliance with industry standards.